Circulating miRNAs as Potential Biomarkers of Age-Related Macular Degeneration
Chengda Ren1, Qingyu Liu1, Qingquan Wei2
1Department of Ophthalmology, Shanghai Tenth people's hospital, Tongji University School of Medicine, Shanghai, China.
Abstract:
Backgroud: Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness of the elder people. This research was intended to demonstrate the different expression of microRNAs (miRNA) in AMD patients and whether they can be used as biomarkers for AMD.
Methods:
MiRNAs expression was measured by microarray of 6 AMD cases and 6 gender matched controls. In a larger-sample case-control study with 126 AMD cases and 140 controls, whole blood samples were detected for the differences of miRNA expression.
Results:
A total of 216 differentially expressed miRNAs (111 increased and 105 decreased miRNAs) were detected from circulating miRNA microarray. Expanded case-control study results showed that the expression of miR-27a-3p, miR-29b-3p and miR-195-5p was increased significantly. Moreover, the level of miR-27a is higher in patients with wet AMD compared to patients with dry AMD. All 3 miRNAs showed a potential diagnostic value for AMD.
Conclusion:
Circulating miRNA levels were significantly varied in AMD patients. Three miRNAs, miR-27a-3p, miR-29b-3p and the miR-195-5p, might be potential diagnostic biomarkers for AMD.
Insights
Age-related macular degeneration (AMD) is a leading cause of blindness. This study identified three microRNAs (miRNAs) in blood that show potential as diagnostic biomarkers for AMD.
Area of Science:
- Ophthalmology
- Molecular Biology
- Biomarker Discovery
Background:
- Age-related macular degeneration (AMD) is a primary cause of irreversible vision loss in older adults.
- Understanding the molecular mechanisms underlying AMD is crucial for developing effective diagnostic tools.
Purpose of the Study:
- To investigate differential microRNA (miRNA) expression in patients with AMD.
- To evaluate the potential of specific miRNAs as diagnostic biomarkers for AMD.
Main Methods:
- Microarray analysis was performed on 6 AMD cases and 6 controls to measure miRNA expression.
- A larger case-control study (126 AMD cases, 140 controls) analyzed whole blood samples for miRNA expression differences.
Main Results:
- 216 differentially expressed miRNAs were identified, with 111 increased and 105 decreased.
- Significant increases in miR-27a-3p, miR-29b-3p, and miR-195-5p expression were observed in AMD patients.
- miR-27a levels were higher in wet AMD compared to dry AMD, indicating potential subtype specificity.
Conclusions:
- Circulating miRNA levels are significantly altered in individuals with AMD.
- miR-27a-3p, miR-29b-3p, and miR-195-5p demonstrate potential as diagnostic biomarkers for AMD.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs